Digoxin reduces cardiac sympathetic activity in severe congestive heart failure

Department of Medicine, Division of Cardiology, Mount Sinai Hospital, Toronto, Ontario, Canada.

OBJECTIVES: This study evaluated the effect of digoxin on cardiac sympathetic activity in patients with congestive heart failure. BACKGROUND: Digoxin favorably alters autonomic tone in heart failure. Whether it reduces cardiac sympathetic drive in the setting of heart failure is unknown. METHODS: Digoxin (0.25 mg intravenously) was administered to 12 patients with severe heart failure and elevated left ventricular end-diastolic pressure (> 14 mm Hg, Group A), 5 patients with less severe heart failure who had normal left ventricular end-diastolic pressure (> 14 mm Hg, Group B) and 6 patients with normal ventricular function. Seven additional patients with heart failure were studied as a time control group. Cardiac and total body norepinephrine spillover, systemic arterial pressure, left ventricular filling pressure and peak positive first derivative of left ventricular pressure were all assessed before and 30 min after administration of digoxin. RESULTS: In Group A there were no changes in hemodynamic variables or total body norepinephrine spillover after digoxin administration; however, there was a significant reduction in cardiac norepinephrine spillover (263 +/- 70 to 218 +/- 62 pmol/min, mean +/- SEM, p < 0.001). In contrast, in Group B, digoxin caused a significant increase in cardiac norepinephrine spillover that was not associated with any hemodynamic changes or a change in total body spillover. There were no hemodynamic changes or a change in total body spillover. There were no hemodynamic or spillover changes in the time control or normal ventricular function group. CONCLUSIONS: Digoxin, in the absence of detectable inotropic or hemodynamic effects, caused a reduction in cardiac norepinephrine spillover in patients with heart failure who had elevated filling pressures. This finding suggests a potentially beneficial primary autonomic action of digoxin in patients with severe heart failure.

This article has been cited by other articles:

				M. Gheorghiade, D. J. van Veldhuisen, and W. S. Colucci Contemporary Use of Digoxin in the Management of Cardiovascular Disorders Circulation, May 30, 2006; 113(21): 2556 - 2564. [Full Text] [PDF]

				M. Gheorghiade, K. F. Adams Jr, and W. S. Colucci Digoxin in the Management of Cardiovascular Disorders Circulation, June 22, 2004; 109(24): 2959 - 2964. [Full Text] [PDF]

				A. Al-Hesayen and J. D. Parker Impaired Baroreceptor Control of Renal Sympathetic Activity in Human Chronic Heart Failure Circulation, June 15, 2004; 109(23): 2862 - 2865. [Abstract] [Full Text] [PDF]

				S. S. Rathore, J. P. Curtis, Y. Wang, M. R. Bristow, and H. M. Krumholz Association of Serum Digoxin Concentration and Outcomes in Patients With Heart Failure JAMA, February 19, 2003; 289(7): 871 - 878. [Abstract] [Full Text] [PDF]

				A. Al-Hesayen, E. R. Azevedo, G. E. Newton, and J. D. Parker The effects of dobutamine on cardiac sympathetic activity in patients with congestive heart failure J. Am. Coll. Cardiol., April 17, 2002; 39(8): 1269 - 1274. [Abstract] [Full Text] [PDF]

				D. J. van Veldhuisen Low-dose digoxin in patients with heart failure: Less toxic and at least as effective? J. Am. Coll. Cardiol., March 20, 2002; 39(6): 954 - 956. [Full Text] [PDF]

				G. Grassi, C. Turri, G. Seravalle, G. Bertinieri, A. Pierini, and G. Mancia Effects of Chronic Clonidine Administration on Sympathetic Nerve Traffic and Baroreflex Function in Heart Failure Hypertension, August 1, 2001; 38(2): 286 - 291. [Abstract] [Full Text] [PDF]

				K.-M. Yee, S. D. Pringle, and A. D. Struthers Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1800 - 1807. [Abstract] [Full Text] [PDF]

				B. S. Huang, M. Kudlac, R. Kumarathasan, and F. H. H. Leenen Digoxin Prevents Ouabain and High Salt Intake-Induced Hypertension in Rats With Sinoaortic Denervation Hypertension, October 1, 1999; 34(4): 733 - 738. [Abstract] [Full Text] [PDF]

				E. R. Azevedo and J. D. Parker Parasympathetic Control of Cardiac Sympathetic Activity : Normal Ventricular Function Versus Congestive Heart Failure Circulation, July 20, 1999; 100(3): 274 - 279. [Abstract] [Full Text] [PDF]

				G. E. Newton, E. R. Azevedo, and J. D. Parker Inotropic and Sympathetic Responses to the Intracoronary Infusion of a ß2-Receptor Agonist : A Human In Vivo Study Circulation, May 11, 1999; 99(18): 2402 - 2407. [Abstract] [Full Text] [PDF]

				E. R. Azevedo, G. E. Newton, and J. D. Parker Cardiac and systemic sympathetic activity in response to clonidine in human heart failure J. Am. Coll. Cardiol., January 1, 1999; 33(1): 186 - 191. [Abstract] [Full Text] [PDF]

				G. A. Rongen, S. C. Brooks, S.-i. Ando, H. R. Dajani, B. L. Abramson, and J. S. Floras Neural and Hypotensive Effects of Angiotensin II Receptor Blockade Hypertension, January 1, 1998; 31(1): 378 - 383. [Abstract] [Full Text] [PDF]

				G. E. Newton and J. D. Parker Cardiac Sympathetic Responses to Acute Vasodilation: Normal Ventricular Function Versus Congestive Heart Failure Circulation, December 15, 1996; 94(12): 3161 - 3167. [Abstract] [Full Text]